th Pharmaceutical Sciences and Innovations in Pharma Industry

Pharmaceutical Sciences andInnovations in Pharma Industry

February 25-26, 2019 Berlin, Germany

19th World Congress on

S C I E N T I F I C P R O G R A M

conferenceseries.com

SCIENTIFIC PROGRAM

Monday, 25th February DAY 1Monday, 25th February

08:30-09:00 Registrations

09:00-09:30 Introduction

09:30-09:50 COFFEE BREAK

09:50-11:50 Meeting Hall 01

KEYNOTE LECTURES

MEETING HALL 01 MEETING HALL 02

11:50-13:10 Talks On: Globalized Pharma Sector

Talks On: Drug Discovery

Pharma and Biotech Financial Outlook Drug Targeting and Design

Digital Pharma Drug Delivery Technologies

Generics versus Big Pharma Smart Drug Delivery Systems

Medico Marketing Entrepreneurs Investment Meet

13:10-13:15 GROUP PHOTO

13:15-14:00 LUNCH BREAK


14:00-16:00 Talks On: Drug Development Talks On: Pharmaceutical Sciences

Discovery and Development Pharma and Biotech Financial Outlook

Preclinical Research Pharmaceutical Process Validation

Clinical Research Pharmaceutical Supply Chain Optimization

Drug Development Companies Tamper-Evident Pharmaceutical Packaging

Drug Characterisation Pharmaceutical Engineering


MEETING HALL 01 (16:20-17:00) MEETING HALL 01 (17:00-18:00)

Young Researchers in Pharmaceutical Sciences 2019

Workshop

https://industry.pharmaceuticalconferences.com/

SCIENTIFIC PROGRAM

Tuesday, 26th February DAY 2Tuesday, 26th February

09:00-10:30 Meeting Hall 01

KEYNOTE LECTURES



10:50-12:50 Talks On: Pharmaceutical Nanotechnology

Talks On: Purpose and Principles of GMP

Characterization of Pharmaceutical Nanotools GMP/GCP Interface & GMP audits

Challenges to Pharmaceutical GMP Requirements & Standards

Nanotechnology in Drug Delivery Tamper-Evident Pharmaceutical Packaging

Pharmaceutical Nanotechnology Clinical Pharmacy and Therapeutics

Future Prospects of Pharmaceutical Nanotechnology FDA Good Manufacturing Practices

12:50-13:35 LUNCH BREAK


13:35-15:55 Talks On: Clinical Pharmacy and Therapeutics

Talks On: Regulatory Requirements for Pharmaceuticals

Clinical trials and drug information Information on Compounding

Outcome research and pharmacoeconomic studies Drug Compliance Programs

Clinical case studies FDA guidance for clinical investigations

Role of pharmacist in communicating and counseling patients Nicotine-Containing Products

Clinical genomics and proteomics Newly Added Guidance Documents


MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)

Poster Presentations Workshop


Previous SpeakersRaymond A HumlQuintiles, USA

Nigel J RulewskiQuintiles, Inc, USA

James Harris Healthcare Economics LLC, USA

Ronald A Rader Biotechnology Information Institute, USA

András Guttman University of Pannonia,Hungary SCIEX, USA

Sumant Chaubey Bills Biotech, India

Tom Carver Wragge Lawrence Graham & Co UK

Andreu Soldevila CEO LeanBioPro, Spain

Sarfaraz K. Niazi TheraProteins, USA

Christoph Volpers Senior Patent Consultant at Michalski & Hüttermann, Germany

Wolfgang A. Rehmann Taylor Wessing, Germany

Marcus Mreyen Protagen Protein Services GmbH Germany

Min Zhang Fujifilm Diosynth Biotechnologies USA

Fiona M Greer SGS Life Sciences, Switzerland

Volker Schellenberger Amunix Operating Inc., USA

Alan L. Epstein USC Keck School of MedicineUSA

Upendra Nagaich Amity Institute of Pharmacy, India

Gene M. Ransom, III University of Maryland and University of Baltimore School of Law, USA

Gordon T. Bolger Nucro-Technics, Canada

Adetunji Olawale Osun State Polytechnic, Nigeria

Angela Furlanetto Dimock Stratton LLP, Canada



Afshin Safavi BioAgilytix , USA

Mariana Babayeva Touro College Of Pharmacy, USA

Andy Upsall BioOutsource, UK

Samantha Little Covance Laboratories Ltd, UK

Kamali Chance Quintiles Inc., USA

Mario DiPaola Blue Stream Laboratories, USA

Francesco Marchesi Regina Elena National Cancer Institute , Italy

Candida Fratazzi BBCR Consulting, USA

Krishna Menon USA

Daniel Galbraith BioOutsource Ltd, UK

Siddhartha Roy CSIR - Indian Institute of Chemical Biology, India

Noelle Sunstrom Neuclone PTY LTD, Australia

Dipti Gulati PJI Biotech, USA

Alexander Pitters Kaiser Optical Systems, France

Laszlo Endrenyi University of Toronto, Canada

Michael G Tovey INSERM , France

Christina Vessely Biologics Consulting , USA

Ruideger Janwosky Cinfa Biotech GmbH, Germany

Christelle Dagoneau Catalent Biologics, USA

Aparna Kasinath Syngene International , India

Denise M Kettelberger Sunstein Kann Murphy & Timbers LLP

Previous Speakers

Glimpses of Pharmaceutical Sciences

Berlin Attractions

Berlin

Cat

hedr

al

Frensehtrum

Berlin

Vict

ory C

olum

n

Staa

tsope

r Ber

lin

Reich

stag

Build

ing

Genda

rmen

mar

kt

Char

lotte

nBur

g pa

lace

Max

resd

efau

lt

Mus

eum

sinse

l Mus

eum

Islan

d Ber

lin

Pharmaceutical Sciences 2019

• Pharmacoeconomics: Open Access

• Journal of Developing Drugs

• Pharmaceutical Regulatory Affairs: Open Access

Important Dates

Abstract submission opens: July 01, 2018

Registration opens: July 01, 2018

On spot registration: February 25, 2019

Contact Us

Missy Christen | Program Director

Pharmaceutical Sciences 2019

47 Churchfield Road, London, W3 6AY

W: https://industry.pharmaceuticalconferences.com/

E: [email protected]

Toll Free: +1-702-508-5200

Venue & Accommodation

Berlin, Germany


th Pharmaceutical Sciences and Innovations in Pharma Industry

Documents

Transcript of th Pharmaceutical Sciences and Innovations in Pharma Industry